Cargando…
Eliminating the need for fasting with oral administration of bisphosphonates
Bisphosphonates are the major treatment of choice for osteoporosis, given that they are attached preferentially by bone and significantly reduce the risk of fractures. Oral bisphosphonates are poorly absorbed (usually less than 1% for nitrogen-containing bisphosphonates) and when taken with food or...
Autores principales: | Pazianas, Michael, Abrahamsen, Bo, Ferrari, Serge, Russell, R Graham G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804538/ https://www.ncbi.nlm.nih.gov/pubmed/24204155 http://dx.doi.org/10.2147/TCRM.S52291 |
Ejemplares similares
-
Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011) -
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010) -
NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
por: Pazianas, Michael
Publicado: (2021) -
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: reply to Yarom and Elad
por: Pazianas, M., et al.
Publicado: (2008) -
Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)